Alimera Sciences Inc.

NASDAQ: ALIM · Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM

Alimera Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
12.09M 5.27M 16.51M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 183K 833K
Other Long-Term Assets
52K n/a n/a
Receivables
34.55M 19.61M 19.13M
Inventory
1.88M 1.6M 2.68M
Other Current Assets
3.94M 2.92M 34K
Total Current Assets
52.42M 29.41M 42.16M
Property-Plant & Equipment
3.59M 3.92M 4.49M
Goodwill & Intangibles
97.36M 8.96M 10.9M
Total Long-Term Assets
101.1M 13.19M 16.36M
Total Assets
153.52M 42.6M 58.52M
Account Payables
8.25M 10.09M 8.71M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a 25.31M n/a
Other Current Liabilities
3.46M 2.29M 2.18M
Total Current Liabilities
21.91M 39.73M 12.59M
Long-Term Debt
64.49M 18.68M 43.08M
Other Long-Term Liabilities
20.95M 5.04M 5.45M
Total Long-Term Liabilities
85.44M 23.72M 48.53M
Total Liabilities
107.35M 63.45M 61.13M
Total Debt
67.4M 44.33M 43.57M
Common Stock
524K 70K 69K
Retained Earnings
-418.49M -415.39M -397.28M
Comprehensive Income
1.69M -3M -1.85M
Shareholders Equity
46.17M -20.85M -2.6M
Total Investments
n/a 183K 833K